Specific Imaging of Bacterial Infection Using 6″-18F-Fluoromaltotriose: A Second-Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria

6″-18F-fluoromaltotriose is a PET tracer that can potentially be used to image and localize most bacterial infections, much like 18F-FDG has been used to image and localize most cancers. However, unlike 18F-FDG, 6″-18F-fluoromaltotriose is not taken up by inflammatory lesions and appears to be specific to bacterial infections by targeting the maltodextrin transporter that is expressed in gram-positive and gram-negative strains of bacteria. Methods: 6″-18F-fluoromaltotriose was synthesized with high radiochemical purity and evaluated in several clinically relevant bacterial strains in cultures and in living mice. Results: 6″-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains. 6″-18F-fluoromaltotriose was also able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection. The utility of 6″-18F-fluoromaltotriose to help monitor antibiotic therapies was also evaluated in rats. Conclusion: 6″-18F-fluoromaltotriose is a promising new tracer that has significant diagnostic utility, with the potential to change the clinical management of patients with infectious diseases of bacterial origin.

[1]  S. Gambhir,et al.  Synthesis of [18F]-labelled Maltose Derivatives as PET Tracers for Imaging Bacterial Infection , 2015, Molecular Imaging and Biology.

[2]  T. Govender,et al.  Preclinical Evaluation of 68Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging , 2014, The Journal of Nuclear Medicine.

[3]  W. Goebel,et al.  Maltose and Maltodextrin Utilization by Listeria monocytogenes Depend on an Inducible ABC Transporter which Is Repressed by Glucose , 2010, PloS one.

[4]  V. Garrido,et al.  In Vivo Monitoring of Staphylococcus aureus Biofilm Infections and Antimicrobial Therapy by [18F]Fluoro-Deoxyglucose–MicroPET in a Mouse Model , 2014, Antimicrobial Agents and Chemotherapy.

[5]  P. Ringwald,et al.  Antimicrobial resistance. , 2001, Emerging infectious diseases.

[6]  Thomas Bjarnsholt,et al.  The in vivo biofilm. , 2013, Trends in microbiology.

[7]  J. Holmgren,et al.  The maltose regulon of Vibrio cholerae affects production and secretion of virulence factors , 1994, Infection and immunity.

[8]  T. Ferenci.  Methyl-alpha-maltoside and 5-thiomaltose: analogs transported by the Escherichia coli maltose transport system , 1980, Journal of bacteriology.

[9]  J. Musser,et al.  Maltodextrin Utilization Plays a Key Role in the Ability of Group A Streptococcus To Colonize the Oropharynx , 2006, Infection and Immunity.

[10]  V. Saini,et al.  A Systematic Approach for Developing Bacteria-Specific Imaging Tracers , 2017, The Journal of Nuclear Medicine.

[11]  K. Kinzler,et al.  Imaging of Musculoskeletal Bacterial Infections by [124I]FIAU-PET/CT , 2007, PloS one.

[12]  D. Weiss,et al.  PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. , 2014, Angewandte Chemie.

[13]  S. Gambhir,et al.  Investigation of 6-[18F]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection , 2014, PloS one.

[14]  S. Abbott,et al.  16S rRNA Gene Sequencing for Bacterial Identification in the Diagnostic Laboratory: Pluses, Perils, and Pitfalls , 2007, Journal of Clinical Microbiology.

[15]  Fatema Z. Chowdhury,et al.  Glycogen and Maltose Utilization by Escherichia coli O157:H7 in the Mouse Intestine , 2008, Infection and Immunity.

[16]  R. Pettigrew,et al.  The use of 14C-FIAU to predict bacterial thymidine kinase presence: implications for radiolabeled FIAU bacterial imaging. , 2013, Nuclear medicine and biology.

[17]  James R. Johnson,et al.  Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging. , 2013, Current topics in medicinal chemistry.

[18]  M. Sathekge,et al.  Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. , 2013, Bioconjugate chemistry.

[19]  T. Ferenci.  The recognition of maltodextrins by Escherichia coli. , 1980, European journal of biochemistry.

[20]  H. Engler,et al.  68Ga-NOTA-UBI-29-41 as a PET Tracer for Detection of Bacterial Infection , 2016, The Journal of Nuclear Medicine.

[21]  Dongin Kim,et al.  Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. , 2011, Nature materials.

[22]  Gooitzen M van Dam,et al.  Targeted imaging of bacterial infections: advances, hurdles and hopes. , 2015, FEMS microbiology reviews.

[23]  M. Pomper,et al.  Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography , 2014, Science Translational Medicine.

[24]  B. Salzberger,et al.  Staphylococcus aureus gene expression in a rat model of infective endocarditis , 2014, Genome Medicine.

[25]  E. Unanue,et al.  Lymphocyte apoptosis during early phase of Listeria infection in mice. , 1997, The American journal of pathology.

[26]  B. Stambuk,et al.  Maltotriose fermentation by Saccharomyces cerevisiae , 2001, Journal of Industrial Microbiology and Biotechnology.

[27]  A. Fauci,et al.  Emerging Infectious Diseases: Threats to Human Health and Global Stability , 2013, PLoS pathogens.

[28]  N. Høiby,et al.  Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model , 2013, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.